ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,709,639, issued on Aug. 18, was assigned to Kite Pharma Inc. (Santa Monica, Calif.).
"Methods of administering chimeric antigen receptor immunotherapy" was invented by Jeffrey S. Wiezorek (Santa Monica, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure provides cells comprising CD19-directed chimeric antigen receptor (CAR) genetically modified autologous T cell immunotherapy for the treatment of, e.g., relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy, including diffuse large B-cell lymphoma (DLBCL) not otherwise specified, primary mediastinal large B-cell lymphoma, high grade B-cell lymphoma, an...